TickerFacts.

Taysha Gene Therapies, Inc. (TSHA): Weighted Average Diluted Shares

Annual figures by period end, from SEC filings.

319.71M
Year ended 2025-12-31
+93.8%
3-year compound annual growth
2021-12-31: 37.65M2022-12-31: 43.95M2023-12-31: 116.12M2024-12-31: 250.13M2025-12-31: 319.71M319.71M
2021-12-31 Weighted Average Diluted Shares (shares) 2025-12-31
Period endedWeighted Average Diluted SharesChange YoYSource filing
2025-12-31319.71M+27.8%2026-03-19, From 2025-01-01
2024-12-31250.13M+115.4%2026-03-19, From 2024-01-01
2023-12-31116.12M+164.2%2025-02-26, From 2023-01-01
2022-12-3143.95M+16.7%2024-03-19, From 2022-01-01
2021-12-3137.65Mn/a2023-03-28, From 2021-01-01